Abstract
This report concerns a 37-year-old chronic schizophrenic patient who derived substantial benefit from the addition of ascorbic acid (vitamin C) to his neuroleptic treatment. The case highlights the potential usefulness of vitamin C as an adjunctive agent in the treatment of chronic schizophrenia.
MeSH terms
-
Adult
-
Ascorbic Acid / administration & dosage
-
Ascorbic Acid / therapeutic use*
-
Chronic Disease
-
Drug Therapy, Combination
-
Haloperidol / administration & dosage
-
Haloperidol / therapeutic use*
-
Humans
-
Male
-
Schizophrenia / drug therapy*
-
Treatment Outcome
Substances
-
Haloperidol
-
Ascorbic Acid